Protocols for vaginal inoculation and sample collection in the experimental mouse model of Candida vaginitis

Journal of Visualized Experiments

Volumn , Issue 58, 2011, Pages

  Yano, Junko ^a   Fidel Jr , Paul L ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Candida albicans; Immunology; Issue 58; Lumbar lymph nodes; Mouse; Vaginal lavage; Vaginal tissues; Vaginitis

Indexed keywords

EID: 83455244288     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/3382     Document Type: Article

References (41)

1. Abraham, M.C., et al. Inducible immunity to Trichomonas vaginalis in a mouse model of vaginal infection. Infect. Immun. 64, 3571 (1996).
2. Black, C.A., et al. Major histocompatibility haplotype does not impact the course of experimentally induced murine vaginal candidiasis. Lab. Anim. Sci. 49 (6), 668 (1999).
3. Black, C.A., et al. Acute neutropenia decreases inflammation associated with murine vaginal candidiasis but has no effect on the course of infection. Inf. Immun. 66, 1273 (1998).
4. Black, C.A., et al. Increased severity of Candida vaginitis in BALB/c nu/nu mice versus the parent strain is not abrogated by adoptive transfer of T cell enriched lymphocytes. J. Reprod. Immunol. 45, 1 (1999).
5. Buchannan, D.L., et al. Role of stromal and epithelial estrogen receptors in vaginal epithelial proliferation, stratification, and cornification. Endocrinology 139 (10), 4345 (1998).
6. Clemons, K.V., et al. Genetic susceptibility of mice to Candida albicans vaginitis correlates with host estrogen sensitivity. Infect. Immun. 72, 4878 (2004).
7. Conrady, C.D., Halford, W.P., & Carr, D.J. Loss of the type I interferon pathway increases vulnerability of mice to genital Herpes simplex virus 2 infection. J. Virol. 85 (4), 1625 (2011).
8. Cunha, G.R., Cooke, P.S., & Kurita T. Role of estromal-epithelial interaction in hormonal responses. Arch Histol Cytol. 67 (5), 417 (2004).
9. Enjalbert, B., et al. A multifunctional, synthetic Caussia princeps luciferase reporter for live imaging of Candida albicans infections, 77 (11), 4847 (2009).
10. Feinen, B., et al. Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection. Mucosal Immunol. 3 (3), 312 (2010).
11. Fidel, P.L. Distinct protective host defenses against oral and vaginal candidiasis. Med. Mycol. 40, 359 (2002).
12. Fidel, P.L., et al. An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect. Immun. 72, 2939 (2004).
13. Fidel, P.L., Cutright, J.L., & Sobel, J.D. Efficacy of D0870 treatment of experimental Candida vaginitis. Antimicrob. Agents. Chemother. 41, 1455 (1997).
14. Fidel P.L., Cutright, J.L., & Steele, C. Effects of Reproductive hormones on experimental vaginal candidiasis. Infect. Immun. 68, 651 (2000).
15. Fidel, P.L., et al. A murine model of Candida glabrata vaginitis. J. Inf. Dis. 173, 425 (1996).
16. Fidel, P.L., et al. Analysis of vaginal cell populations during experimental vaginal candidiasis. Inf. Immun. 67, 3135 (1999).
17. Fidel, P.L., Lynch, M.E., & Sobel, J. D. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Infect. Immun. 61, 1990 (1993).
18. Fidel, P.L. & Sobel, J.D. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin. Microbiol. Rev. 9, 335 (1996).
19. Fidel, P.L. & Sobel, J.D. Murine Models of Candida Vaginal Infections, In Experimental models in antimicrobial chemotherapy, 2nd ed., O. Zak & M. Sande, eds. (Academic Press Ltd, London, UK), 741-748 (1999).
20. Fidel, P.L., Vazquez, J.A., & Sobel, J. D. Candida glabrata: Review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin. Microbiol. Rev. 12, 80 (1999).
21. Fulurija, A., Ashman, R.B., & Papadimitriou, J. M. Neutrophil depletion increases susceptibility to systemic and vaginal candidiasis in mice, and reveals differences between brain and kidney in mechanisms of host resistance. Microbiology. 142, 3487 (1996).
22. Gill, N., et al. NK cells require type I IFN receptor for antiviral responses during genital HSV-2 infection. Cell Immunol 269 (1), 29 (2011).
23. Hamad, M., Abu-Elteen, K.H., & Ghaleb, M. Estrogen-dependent induction of persistent vaginal candidosis in naive mice. Cell. Immunol. 47 (7), 304 (2004).
24. Hamad, M., et al. Utility of the oestrogen-dependent vaginal candidosis murine model in evaluating the efficacy of various therapies against vaginal Candida albicans infection. Mycoses. 49 (2), 104 (2006).
25. LeBlanc, D.M., Barousse M.M., & Fidel, P. L. A role for dendritic cells in immunoregulation during experimental vaginal candidiasis. Infect. Immun. 74, 3213 (2006).
26. McGrory, T., & Garber, G.E. Mouse intravaginal infection with Trichomonas vaginalis and role of Lactobacillus acidophilus in sustaining infection, Infect. Immun. 60, 2375-2379 (1992).
27. Naglik, J.R., Fidel, P.L., & Odds, F. C. Animal models of mucosal Candida infection. FEMS. Microbiol. Lett. 283 (2), 129 (2008).
28. Nomanbhoy, F., et al. Vaginal and oral epithelial cell anti-Candida activity. Inf. Immun. 70, 7081 (2002).
29. Pietrella, D., et al. A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique. Vaccine. 28 (7), 1717 (2010).
30. Redondo-Lopez, V., Cook, R.N., & Sobel, J.D. Emerging role of Lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis. 12 (5), 856 (1990).
31. Saavedra, M., et al. Local production of chemokines during experimental vaginal candidiasis. Inf. Immun. 67, 5820 (1999).
32. Sobel, J.D. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann. N. Y. Acad. Sci. 544, 547 (1988).
33. Sobel, J.D. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin. Infect. Dis. 14 (Suppl 1), S148-S153 (1992).
34. Sobel, J.D., et al. Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations. Am. J. Obstet. Gynecol. 178 (2), 203 (1998).
35. Song, W., et al. Local and humoral immune responses against primary and repeat Neisseria gonorrhoeae genital tract infections of 17β-estradiol-treated mice. Vaccine. 26, 5741 (2008).
36. Taylor, B.N., et al. In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus. J. Infect. Dis. 182, 955 (2000).
37. Taylor, B.N., Saavedra, M., & Fidel, P.L. Local Th1/Th2 cytokine production during experimental vaginal candidiasis. Med. Mycol. 38, 419 (2000).
38. Tirabassi, R.S., et al. A mucosal vaccination approach for herpes simplex virus type 2. Vaccine. 29 (5), 1090 (2011).
39. Van den Broeck, W., Derore, A., & Simoens, P. Anatomy and nomenclature of murine lymph nodes: descriptive and nomenclatory standardization in BALB/cAnNCrl mice. J. Immunol. Methods 312 (1-2), 12 (2006).
40. Wormley, F.L., Chaiban, J., & Fidel, P.L. Cell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis. J. Immunol. Methods. 69, 5072 (2001).
41. Yano, J., et al. Epithelial cell-derived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during Candida vaginitis. Infect. Immun. 78 (12), 5126 (2010).